New Publications in 2023-24 That Should Change NICU Care

---

ONLINECMECNENEO Grand Rounds

Instructions

Tuesday, July 9, 2024, 8:00 AM - Thursday, July 8, 2027, 11:59 PM, Online


AMA PRA Category 1 Credits™ (1.00 hours), ANCC Nursing Contact Hour(s) (1.00 hours), Non-Physician (Attendance) (1.00 hours)

This presentation will review recently published articles that should influence health care decisions for neonates who need intensive care: the role of human milk feedings in improving health outcomes and reducing neonatal morbidities; a recent trial evaluating the safety and efficacy of ibuprofen for closing the PDA; the role of oral valganciclovir for treatment in infants with congenital cytomegalovirus and an abnormal hearing screen; and, “How much oxygen is too much oxygen in infants born with significant perinatal distress?” At the conclusion of this activity, learners will critically evaluate the information to determine if any changes in treatment are merited and if so, initiate an evidenced-based intervention in their NICU.

1. Discuss the role of supplementation with human milk-based fortifier (HMBF), as compared to bovine milk-based fortifier to reduce the incidence of necrotizing enterocolitis, sepsis, and mortality in extremely preterm infants exclusively fed human milk.
2. Describe role of human milk feedings in improving health outcomes and reducing neonatal morbidities.
3. Evaluate the safety and efficacy of ibuprofen for closing the patent ductus arteriosus.
4. Discuss the role of oral valganciclovir for treatment in infants with congenital cytomegalovirus and an abnormal hearing screen.
5. Examine the results of a recent clinical trial comparing eat, sleep, console approach, or usual care for neonatal opioid withdrawal.

1. Discuss the role of supplementation with human milk-based fortifier (HMBF), as compared to bovine milk-based fortifier to reduce the incidence of necrotizing enterocolitis, sepsis, and mortality in extremely preterm infants exclusively fed human milk.
2. Describe role of human milk feedings in improving health outcomes and reducing neonatal morbidities.
3. Evaluate the safety and efficacy of ibuprofen for closing the patent ductus arteriosus.
4. Discuss the role of oral valganciclovir for treatment in infants with congenital cytomegalovirus and an abnormal hearing screen.
5. Examine the results of a recent clinical trial comparing eat, sleep, console approach, or usual care for neonatal opioid withdrawal.

The Pediatrix Center for Research, Education, Quality and Safety is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Pediatrix Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

---

The Pediatrix Center for Research, Education, Quality and Safety is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The Pediatrix Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 1.00 nursing contact hour(s). Participants should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

The Pediatrix Center for Research, Education, Quality and Safety adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies during the past 24 months prior to their involvement with the CE activity. All relevant financial relationships have been mitigated prior to the commencement of the activity.

There is no commercial support for this educational activity.